Title : Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells.

Pub. Date : 2015 Mar 15

PMID : 25681335






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In this article, we show that TGF-beta1 and IL-10 expression in CTCL cells is regulated by NF-kappaB and suppressed by bortezomib (BZ), which has shown promising results in the treatment of CTCL. Bortezomib TSPY like 2 Homo sapiens
2 In this article, we show that TGF-beta1 and IL-10 expression in CTCL cells is regulated by NF-kappaB and suppressed by bortezomib (BZ), which has shown promising results in the treatment of CTCL. Bortezomib TSPY like 2 Homo sapiens
3 In this article, we show that TGF-beta1 and IL-10 expression in CTCL cells is regulated by NF-kappaB and suppressed by bortezomib (BZ), which has shown promising results in the treatment of CTCL. Bortezomib TSPY like 2 Homo sapiens
4 In this article, we show that TGF-beta1 and IL-10 expression in CTCL cells is regulated by NF-kappaB and suppressed by bortezomib (BZ), which has shown promising results in the treatment of CTCL. Bortezomib TSPY like 2 Homo sapiens
5 TGF-beta1 suppression decreases CTCL cell viability and increases apoptosis, and adding exogenous TGF-beta1 increases viability of BZ-treated CTCL cells, indicating TGF-beta1 prosurvival function in CTCL cells. Bortezomib TSPY like 2 Homo sapiens
6 TGF-beta1 suppression decreases CTCL cell viability and increases apoptosis, and adding exogenous TGF-beta1 increases viability of BZ-treated CTCL cells, indicating TGF-beta1 prosurvival function in CTCL cells. Bortezomib TSPY like 2 Homo sapiens
7 Importantly, our results demonstrate that BZ inhibits expression of the chemokine receptor CXCR4 in CTCL cells, resulting in their decreased migration, and that the CTCL cell migration is mediated by TGF-beta1. Bortezomib TSPY like 2 Homo sapiens